Admetsys
Admetsys is a biomedical technology company specializing in critical care automation. The company's flagship PrecisionOne system is the first fully automated glycemic control system and continuous blood diagnostics platform for hospital care. The company was founded to commercialize the next generation of medical automation technology: continuous real-time biosensing, robotics, artificial intelligence and learning algorithms, intelligent therapeutic delivery, and advanced data telemetry.
Growth Trajectory
Admetsys's growth potential lies in expanding its blood analyte measurement capabilities, commercializing its technology in the USA pending FDA clearance, and securing wider adoption in the EU and EEA. They also have opportunities in integrating with various biosensors and infusion pumps, and further improving their AI-driven metabolic modeling.
Technical Challenges
Tech Stack
Team Size
Key Risks
Opportunities
Access Our Live VC Funding Database
30,000+ funded startups
tracked in the last 3 months
B2B verified emails
of key decision makers
Growth metrics
Real-time company performance data
Live updates
of new VC funding rounds
Advanced filters
for sophisticated queries
API access
with multiple export formats